Piramal Pharma Ltd
Peter DeYoung is the current CEO, Global Pharma at Piramal Pharma Limited, overseeing Piramal Pharma Solutions and Piramal Critical Care. With a background in private equity and consulting, Peter has held various leadership roles in the pharmaceutical industry. DeYoung holds an MBA from Stanford University Graduate School of Business and a BSE in Computer Science from Princeton University.
Piramal Pharma Ltd
2 followers
Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through its 17 global facilities, which include end-to-end development and manufacturing capabilities, and a distribution network in over 100 countries. PPL’s manufacturing arm (Piramal Pharma Solutions), its position as one of the leading producer of Inhaled Anesthetics and a global player in Hospital Generics, and its Consumer Products Division make it a leading player in the global pharmaceutical business.